` Comparison: QGEN, 207940 - Alpha Spread

QGEN
vs
207940

Over the past 12 months, QGEN has underperformed Samsung Biologics Co Ltd, delivering a return of +5% compared to the Samsung Biologics Co Ltd's +11% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
QGEN
207940
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

QGEN Intrinsic Value
45.87 USD
Overvaluation 6%
Intrinsic Value
Price
Intrinsic Value
671 019.95 KRW
Overvaluation 35%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Qiagen NV
NYSE:QGEN
48.96 USD
Samsung Biologics Co Ltd
KRX:207940
1 037 000 KRW
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
QGEN, 207940

QGEN
207940
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Qiagen NV
Revenue
Samsung Biologics Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
QGEN, 207940

QGEN
207940
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Qiagen NV
NYSE:QGEN
Samsung Biologics Co Ltd
KRX:207940
What is Free Cash Flow?

Gross Margin

QGEN
63.7%
Samsung Biologics Co Ltd
53.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

Operating Margin

QGEN
26.4%
Samsung Biologics Co Ltd
32.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

Net Margin

QGEN
18.3%
Samsung Biologics Co Ltd
26.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

FCF Margin

QGEN
24.3%
Samsung Biologics Co Ltd
2.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

ROE

QGEN
10.8%
Samsung Biologics Co Ltd
12%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

ROA

QGEN
6.6%
Samsung Biologics Co Ltd
7.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

ROIC

QGEN
8.8%
Samsung Biologics Co Ltd
8.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

ROCE

QGEN
11.7%
Samsung Biologics Co Ltd
12.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Qiagen NV
Samsung Biologics Co Ltd

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
QGEN, 207940

Loading
QGEN
207940
Add Stock
www.alphaspread.com

Performance Gap
QGEN, 207940

Loading
QGEN
207940
Difference
www.alphaspread.com

Performance By Year
QGEN, 207940

Loading
QGEN
207940
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare QGEN to other stocks
Unlock Full Access to Alpha Spread
Create Free Account